....the trio will make their case to the Senate this week
Three of President Donald Trump's Cabinet picks will face the scrutiny of Senate committees this week -- Tulsi Gabbard, Robert F. Kennedy Jr. and Kash Patel.
Director of national intelligence nominee Gabbard’s hearing will take place Thursday morning before the Senate Select Committee on Intelligence.
The former Democratic congresswoman and onetime Democratic presidential candidate has stirred up waves of controversy from across the political spectrum and is expected to face a bruising confirmation battle.
However, Vice President JD Vance remained adamant in supporting Trump's nomination of Gabbard, telling CBS News’ Margaret Brennan on "Face the Nation" on Sunday, “I feel confident that Tulsi Gabbard will ultimately get through.”
“She is a career military servant who's had a classification at the highest levels for nearly two decades. She has impeccable character, impeccable record of service, and she also is a person who I think is going to bring some trust back to the intelligence services,” Vance said during his first interview since becoming vice president.
Also on Thursday, FBI director nominee Kash Patel, who served in several roles in Trump's first administration, will appear before the Senate Judiciary Committee for his confirmation hearing.
Health and Human Services nominee Robert F. Kennedy Jr. will face the Senate Finance Committee on Wednesday morning. Kennedy has faced criticism over his history of remarks against vaccines and his recent vaccine skepticism. In addition to asking the federal government to revoke authorization of COVID-19 vaccines in 2021, and medical experts have expressed concerns over his views potentially spreading medical misinformation.
Kennedy continues to echo Trump's views. On Sunday, he sent out a fundraising email called Trump's executive order withdrawing the U.S. from the World Health Organization "a massive win" for Kennedy's health agenda and for Americans' "fundamental medical freedom rights."
Trump's withdrawal, which has been criticized by medical and health experts, "marks a turning point for our nation. No more subservience to a globalist organization prioritizing profits over American lives and health," Kennedy said in his fundraiser.
